论文部分内容阅读
法国研究者在2011年11月10日在线发表于《Arthritis Care&Research》的报告中称,患类风湿关节炎相关性系统性血管炎的患者对利妥昔单抗治疗反应良好。有3/4的系统性类风湿血管炎(SRV)患者在每日接受利妥昔单抗治疗后病情得到完
French researchers in the November 10, 2011 online “Arthritis Care & Research” report said that patients with rheumatoid arthritis-associated systemic vasculitis respond well to rituximab. Three-quarters of patients with systemic rheumatoid arthritis (SRV) were treated with daily rituximab